Søg
 

Publikationer

Randomiserede kontrollerede studier, litteraturoversigter og anden litteratur om evidensbaseret psykiatri fra Psykiatrisk Forskningsenhed

2021

Storebø OJ, Ribeiro JP, Kongerslev MT, et al. Individual participant data systematic reviews with meta-analyses of psychotherapies for borderline personality disorder. BMJ Open 2021;11:e047416. doi: 10.1136/bmjopen-2020-047416

2020

     

Beck E, Bo S, Jørgensen MS, Gondan M, Poulsen S, Storebø OJ, m.fl. Mentalization-based treatment in groups for adolescents with borderline personality disorder: a randomized controlled trial. J Child Psychol Psychiatry. 2020;61(5):594–604.
https://doi.org/10.1111/jcpp.13152
 
Darling Rasmussen P, Storebø OJ. Attachment and Epigenetics: A Scoping Review of Recent Research and Current Knowledge. Psychol Rep. 5. februar 2020;33294120901846.
https://doi.org/10.1177/0033294120901846
 
Fjermestad-Noll J, Ronningstam E, Bach B, Storebø OJ, Rosenbaum B, Simonsen E. Psychotherapeutic Treatment of Depressive Symptoms in Patients with Narcissistic Disturbances: A Review. J Contemp Psychother. 2020;50(1):21–8.
https://doi.org/10.1007/s10879-019-09437-4

Ganslev  CA, Storebø  OJ, Callesen  HE, Ruddy  R, Søgaard  U. Psychosocial interventions for conversion and dissociative disorders in adults. Cochrane Database of Systematic Reviews 2020, Issue 7. Art. No.: CD005331. DOI: 10.1002/14651858.CD005331.pub3.  
 
Jørgensen MS, Storebø OJ, Simonsen E. Systematic Review and Meta-Analyses of Psychotherapies for Adolescents With Subclinical and Borderline Personality Disorder: Methodological Issues. Can J Psychiatry. 2020;65(1):59–60.
https://doi.org/10.1177/0706743719893893
 
Stoffers-Winterling J, Storebø OJ, Lieb K. Pharmacotherapy for Borderline Personality Disorder: an Update of Published, Unpublished and Ongoing Studies. Current Psychiatry Reports. 2020;22(8). https://link.springer.com/epdf/10.1007/s11920-020-01164-1

Stoffers-Winterling J, Storebø OJ, Simonsen E, Lieb K. Störungsspezifische Psychotherapie der Borderline-Persönlichkeitsstörung. Psychotherapeut.2020. https://doi.org/10.1007/s00278-020-00443-9

Storebø OJ, Gluud C. Methylphenidate for ADHD rejected from the WHO Essential Medicines List due to uncertainties in benefit-harm profile. BMJ Evidence-Based Medicine 2020.
https://ebm.bmj.com/content/early/2020/04/24/bmjebm-2019-111328


Storebø OJ, Stoffers-Winterling JM, Völlm BA, Kongerslev MT, Mattivi JT, Jørgensen MS, m.fl. Psychological therapies for people with borderline personality disorder. Cochrane Database of Systematic Reviews 2020;5.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012955.pub2/full
Podcast
 

2019

Darling Rasmussen P, Storebø OJ, Løkkeholt T, Voss LG, Shmueli-Goetz Y, Bojesen AB, m.fl. Attachment as a Core Feature of Resilience: A Systematic Review and Meta-Analysis. Psychol Rep. august 2019;122(4):1259–96.
https://doi.org/10.1177/0033294118785577

Faltinsen EG, Storebø OJ, Gluud C. Methodological concerns with network meta-analysis on drugs for attention deficit hyperactivity disorder. European Child & Adolescent Psychiatry. 2019 Jan;28(1):145–6.
https://doi.org/10.1007/s00787-018-1164-6

Faltinsen  E, Todorovac  A, Hróbjartsson  A, Gluud  C, Kongerslev  MT, Simonsen  E, Storebø  OJ. Placebo, usual care and waitlist interventions for all mental health disorders. Cochrane Database of Systematic Reviews 2019, Issue 1.
Art. No.: MR000050. DOI: 10.1002/14651858.MR000050.
 Protocol.

Jørgensen MS, Storebø OJ, Simonsen E. Systematic Review and Meta-Analyses of Psychotherapies for Adolescents With Subclinical and Borderline Personality Disorder: Methodological Issues. Can J Psychiatry. 9. december 2019;706743719893893.
https://doi.org/10.1177/0706743719893893

Krogh HB. Methodological advantages and disadvantages of parallel and crossover randomised clinical trials on methylphenidate for attention deficit hyperactivity disorder: a systematic review and meta-analyses.
BMJ Open 2019;9:e026478. 
10.1136/bmjopen-2018-026478   

Storebø OJ. Methylphenidate benefits and harms in children and adolescents with attention deficit/hyperactivity disorder: Two Cochrane systematic reviews. Movement and Nutrition in Health and Disease [Internet]. 26. juni 2019 [henvist 4. februar 2020];3(0).
https://www.movement-nutrition.de/article/view/15

Storebø OJ, Elmose Andersen M, Skoog M, Joost Hansen S, Simonsen E, Pedersen N, m.fl. Social skills training for attention deficit hyperactivity disorder (ADHD) in children aged 5 to 18 years. Cochrane Database Syst Rev. 21 2019;6:CD008223. 
https://doi.org/10.1002/14651858.CD008223.pub3 

 

2018

Darling Rasmussen P, Storebø OJ, Løkkeholt T, Voss LG, Shmueli-Goetz Y, Bojesen AB, et al. Attachment as a Core Feature of Resilience: A Systematic Review and Meta-Analysis. Psychol Rep. 2018 Jan 1;33294118785577.
https://doi.org/10.1177/0033294118785577

Faltinsen EG, Gluud C, Simonsen E, Zwi M, Storebø OJ. Unbalanced risk-benefit analysis of ADHD drugs. The Lancet Psychiatry. 1. november 2018;5(11):870. https://doi.org/10.1016/S2215-0366(18)30334-1

Faltinsen EG, Storebø OJ, Jakobsen JC, Boesen K, Lange T, Gluud C. Network meta-analysis: the highest level of medical evidence? BMJ Evidence-Based Medicine. 1. april 2018;23(2):56–9.
https://doi.org/10.1136/bmjebm-2017-110887
 
Faltinsen EG, Storebø OJ, Gluud C. Methodological concerns with network meta-analysis on drugs for attention deficit hyperactivity disorder. European Child & Adolescent Psychiatry. januar 2019;28(1):145–6.
https://doi.org/10.1007/s00787-018-1164-6
 
Faltinsen E, Zwi M, Castells X, Gluud C, Simonsen E, Storebø OJ. Updated 2018 NICE guideline on pharmacological treatments for people with ADHD: a critical look. BMJ Evid Based Med. 10. december 2018;
https://doi.org/10.1136/bmjebm-2018-111110
 
Marcussen M, Nørgaard B, Arnfred S. The Effects of Interprofessional Education in Mental Health Practice: Findings from a Systematic Review. Acad Psychiatry. 2018; 43(2)
https://doi.org/10.1007/s40596-018-0951-1
 
Ramstad E, Storebø OJ, Gerner T, Krogh HB, Holmskov M, Magnusson FL, m.fl. Hallucinations and other psychotic symptoms in response to methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder: a Cochrane systematic review with meta-analysis and trial sequential analysis. Scandinavian Journal of Child and Adolescent Psychiatry and Psychology. 28. maj 2018;6(1):52–71.
https://doi.org/10.21307/sjcapp-2018-003

Rasmussen PD, Storebø OJ. Is it time for case formulation to outweigh the classical diagnostic classification in child and adolescent psychiatry? Scandinavian Journal of Child and Adolescent Psychiatry and Psychology. 2018;6(4):150–1.
https://doi.org/10.21307/sjcapp-2018-020
 
Rasmussen P, Storebø OJ, Løkkeholt T, Voss LG, Shmueli-Goetz Y, Bojesen AB, m.fl. Attachment as a Core Feature of Resilience: A Systematic Review and Meta-Analysis. Psychol Rep. 29. juni 2018;33294118785577.
https://doi.org/10.1177/0033294118785577
 
Stoffers‐Winterling JM, Storebø OJ, Völlm BA, Mattivi JT, Nielsen SS, Kielsholm ML, m.fl. Pharmacological interventions for people with borderline personality disorder. Cochrane Database of Systematic Reviews. 2018;(2).  https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012956/abstract
 
Storebø OJ. Evidensen for medisinsk behandling av AD/HD er usikker. Kommentar. Tidsskrift for Den norske legeforening. 2018. https://tidsskriftet.no/2018/02/kommentar/evidensen-medisinsk-behandling-av-adhd-er-usikker
 
Storebø OJ, Faltinsen E, Zwi M, Simonsen E, Gluud C. The Jury Is Still Out on the Benefits and Harms of Methylphenidate for Children and Adolescents With Attention-Deficit/Hyperactivity Disorder. Clin Pharmacol Ther. oktober 2018;104(4):606–9.
https://doi.org/10.1002/cpt.1149
 
Storebø OJ, Pedersen N, Ramstad E, Kielsholm ML, Nielsen SS, Krogh HB, m.fl. Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies. Cochrane Database Syst Rev. 9. maj 2018;5:CD012069.
https://doi.org/10.1002/14651858.CD012069.pub2

Storebø OJ, Stoffers‐Winterling JM, Völlm BA, Kongerslev MT, Mattivi JT, Kielsholm ML, m.fl. Psychological therapies for people with borderline personality disorder. Cochrane Database of Systematic Reviews. 2018;(2). Protocol. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012955/abstract

Vibholm HA, Pedersen J, Faltinsen E, Marcussen MH, Gluud C, Storebø OJ. Training, executive, attention and motor skills (TEAMS) training versus standard treatment for preschool children with attention deficit hyperactivity disorder: a randomised clinical trial. BMC Res Notes. 8. juni 2018;11(1):366.
https://doi.org/10.1186/s13104-018-3478-3

2017

 
Boesen K, Saiz LC, Erviti J, Storebø OJ, Gluud C, Gøtzsche PC, Jørgensen KJ.  Boesen K. The Cochrane Collaboration withdraws a review on methylphenidate for adults with attention deficit hyperactivity disorder. Evidence-Based Medicine 2017;22:143-147. 
Christiansen OG, Madsen MT, Simonsen E, Gögenur I. Prophylactic antidepressant treatment following acute coronary syndrome: A systematic review of randomized controlled trials. J Psychiatr Res. 2017 Jul 19;94:186–93.
Faltinsen EG, Kongerslev M, Storebø OJ. Reviews and Meta-analyses of Psychotherapy Efficacy for Borderline Personality Disorder. JAMA Psychiatry. 2017 Aug 1;74(8):853–4.
Storebø OJ, Pedersen N, Ramstad E, Krogh HB, Moreira-Maia CR, Magnusson FL et al. Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents – assessment of harmful effects innon-randomised studies. Cochrane Database Syst Rev 2017 Feb ;5:CD012069

 

2016

Beck E, Bo S, Gondan M, Poulsen S, Pedersen L, Pedersen J, et al. Mentalization-based treatment in groups for adolescents with borderline personality disorder (BPD) or subthreshold BPD versus treatment as usual (M-GAB): study protocol for a randomized controlled trial. Trials. 2016 Jul 12;17(1):314.

Jensen CM, Amdisen BL, Jørgensen KJ, Arnfred SMH. Cognitive behavioural therapy for ADHD in adults: systematic review and meta-analyses. Atten Defic Hyperact Disord. 2016 Mar;8(1):3–11.
Storebø O, Pedersen N, Ramstad E, Krogh HB, Moreira-Maia CR, Magnusson FL, et al. Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of harmful effects in non-randomised studies. Cochrane Database of Systematic Reviews. 2016 Feb;(2).
Storebø OJ, Simonsen E, Gluud C. Methylphenidate for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. JAMA. 2016 May 10;315(18):2009–10.
Storebø OJ, Rasmussen PD, Simonsen E. Association Between Insecure Attachment and ADHD: Environmental Mediating Factors. J Atten Disord. 2016 Feb;20(2):187–96.
Storebø OJ, Simonsen E. The Association Between ADHD and Antisocial Personality Disorder (ASPD): A Review. J Atten Disord. 2016 Oct;20(10):815–24.
Waldemar AK, Arnfred SM, Petersen L, Korsbek L. Recovery-Oriented Practice in Mental Health Inpatient Settings: A Literature Review. Psychiatr Serv. 2016 Jun 1;67(6):596–602
Storebø OJ, Simonsen E, Gluud C. The evidence base of methylphenidate for children and adolescents with attention-deficit hyperactivity disorder is in fact flawed. Eur Child Adolesc Psychiatry. 2016 Sep;25(9):1037–8.
Storebø OJ, Simonsen E, Gluud C. Methylphenidate for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. JAMA. 2016 May 10;315(18):2009–10. 
Storebø OJ, Zwi M, Moreira-Maia CR, Skoog M, Groth C, Gillies D, et al. Response to “Trust, but verify” by Banaschewski et al. Z Kinder Jugendpsychiatr Psychother. 2016;44(5):334–5. 
Storebø OJ, Simonsen E, Gluud C. Methylphenidate for Attention-Deficit/Hyperactivity Disorder-Reply. JAMA. 2016 Sep 6;316(9):995. 
Storebø OJ, Zwi M, Krogh HB, Moreira-Maia CR, Holmskov M, Gillies D, et al. Evidence on methylphenidate in children and adolescents with ADHD is in fact of “very low quality.” Evid Based Ment Health. 2016;19(4):100–2. 
Storebø OJ, Simonsen E, Gluud C. The evidence base of methylphenidate for children and adolescents with attention-deficit hyperactivity disorder is in fact flawed. Eur Child Adolesc Psychiatry. 2016 Sep;25(9):1037–8. 
 

Fik du svar på dit spørgsmål?


Oprettet
29.08.17
Opdateret
22.06.21
Andre sider under Center for Evidensbaseret Psykiatri
 

 Kontakt

 
Psykiatrien Region Sjælland
Center for Evidensbaseret Psykiatri
Fælledvej 6
Bygning 3, 4. sal
4200 Slagelse
Tlf. 24 96 59 17